BCC Research
View Existing Reports | Report Subscriptions | Upcoming Reports | Press Room
 

Biotechnology

Therapeutics and Diagnostics for Women's Disorders  

Report Code: BIO043D, Published: March 2009

 
Also see:
  BIO043C - May 2005
  BIO043B - January 2001

 

The Report:

  • The U.S. market for therapeutics and diagnostics for women’s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%.
  • The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013.
  • Reproductive related therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%.

 

Report Code: BIO043D, Published: March 2009, Analyst: Melissa Elder

 
 

   Bookmark and Share


   


All transactions on our web site are conducted on a Secure SSL Server.
Copyright 2010 © All rights reserved.   About Us | Contact Us | Careers | Privacy Policy  |  Site Map |  XML Map